Terms: = Sarcomas AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
27 results:
1. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T; Yoshino K; Nakamura M; Kato H; Ito T; Maekawa T; Fujisawa Y; Matsushita S; Amagai R; Yamazaki E; Takahashi M; Tamabuchi E; Hashimoto A; Kambayashi Y; Yamazaki N; Miyata T; Asano Y
Exp Dermatol; 2024 Jan; 33(1):e14976. PubMed ID: 37946551
[TBL] [Abstract] [Full Text] [Related]
2. Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.
Connolly NP; Galisteo R; Xu S; Bar EE; Peng S; Tran NL; Ames HM; Kim AJ; Woodworth GF; Winkles JA
Glia; 2021 Sep; 69(9):2199-2214. PubMed ID: 33991013
[TBL] [Abstract] [Full Text] [Related]
3. Rice starch coated iron oxide nanoparticles: A theranostic probe for photoacoustic imaging-guided photothermal cancer therapy.
Vo TMT; Mondal S; Nguyen VT; Park S; Choi J; Bui NT; Oh J
Int J Biol Macromol; 2021 Jul; 183():55-67. PubMed ID: 33857520
[TBL] [Abstract] [Full Text] [Related]
4. Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma.
Zhang J; Chen M; Zhao Y; Xiong H; Sneh T; Fan Y; Wang J; Zhou X; Gong C
Eur J Pharmacol; 2020 Jul; 879():173121. PubMed ID: 32339514
[TBL] [Abstract] [Full Text] [Related]
5. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via pai-1-Sox2 axis.
Zhang Y; Pan Y; Xie C; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
[TBL] [Abstract] [Full Text] [Related]
6. Phage display-derived oligopeptide-functionalized probes for in vivo specific photoacoustic imaging of osteosarcoma.
Ma Z; Qin H; Chen H; Yang H; Xu J; Yang S; Hu J; Xing D
Nanomedicine; 2017 Jan; 13(1):111-121. PubMed ID: 27621054
[TBL] [Abstract] [Full Text] [Related]
7. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract] [Full Text] [Related]
8. In vivo photoacoustic imaging of osteosarcoma in a rat model.
Hu J; Yu M; Ye F; Xing D
J Biomed Opt; 2011 Feb; 16(2):020503. PubMed ID: 21361659
[TBL] [Abstract] [Full Text] [Related]
9. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Mizuno TM; Shen GX
Endocrinology; 2010 Sep; 151(9):4455-66. PubMed ID: 20630999
[TBL] [Abstract] [Full Text] [Related]
10. pai1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the alphavbeta5 and alpha5beta1 integrins.
Vial D; McKeown-Longo PJ
J Cell Sci; 2008 May; 121(Pt 10):1661-70. PubMed ID: 18445685
[TBL] [Abstract] [Full Text] [Related]
11. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract] [Full Text] [Related]
12. Antibodies to pai-1 alter the invasive and migratory properties of human tumour cells in vitro.
Brooks TD; Slomp J; Quax PH; De Bart AC; Spencer MT; Verheijen JH; Charlton PA
Clin Exp Metastasis; 2000; 18(6):445-53. PubMed ID: 11592301
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of a 95 kDa high affinity human high density lipoprotein-binding protein.
Bocharov AV; Vishnyakova TG; Baranova IN; Patterson AP; Eggerman TL
Biochemistry; 2001 Apr; 40(14):4407-16. PubMed ID: 11284697
[TBL] [Abstract] [Full Text] [Related]
14. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA
Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592
[TBL] [Abstract] [Full Text] [Related]
15. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1.
Liu C; Yao J; de Belle I; Huang RP; Adamson E; Mercola D
J Biol Chem; 1999 Feb; 274(7):4400-11. PubMed ID: 9933644
[TBL] [Abstract] [Full Text] [Related]
16. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (pai-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous pai-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract] [Full Text] [Related]
17. Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.
Tsuchiya H; Sunayama C; Okada G; Matsuda E; Tomita K; Binder BR
Anticancer Res; 1997; 17(1A):313-6. PubMed ID: 9066670
[TBL] [Abstract] [Full Text] [Related]
18. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region.
Maurer F; Medcalf RL
J Biol Chem; 1996 Oct; 271(42):26074-80. PubMed ID: 8824249
[TBL] [Abstract] [Full Text] [Related]
19. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract] [Full Text] [Related]
20. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract] [Full Text] [Related]
[Next]
